EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Dexmedetomidine’s Effects on the Livers and Kidneys of Rats with Pancreatic Ischemia-Reperfusion Injury

Hasan Bostancı, Selin Erel iD, Ayşegül Küçük iD, Gülay Kip, Şaban Cem Sezen iD, Seda Gokgoz, Muharrem Atlı, Feyza Aktepe, Kursat Dikmen, Mustafa Arslan iD, Mustafa Kavutçu

Drug Design, Development and Therapy · 2024

DOI: 10.2147/dddt.s441773 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2024. Verfasst von Hasan Bostancı und 10 weiteren Autor:innen. Beteiligte Einrichtung: Gazi University Faculty of Medicine, Department of General Surgery, Ankara, Turkey. Hauptthemen laut MEDLINE: Reperfusion Injury, Dexmedetomidine, Kidney, Liver. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Pancreatic surgeries inherently cause ischemia-reperfusion (IR) injury, affecting not only the pancreas but also distant organs. This study was conducted to explore the potential use of dexmedetomidine, a sedative with antiapoptotic, anti-inflammatory, and antioxidant properties, in mitigating the impacts of pancreatic IR on kidney and liver tissues.

Methods

A total of 24 rats were randomly divided into four groups: control (C), dexmedetomidine (D), ischemia reperfusion (IR), and dexmedetomidine ischemia reperfusion (D-IR). Pancreatic ischemia was induced in the IR and D-IR groups. Dexmedetomidine was administered intraperitoneally to the D and D-IR groups. Liver and kidney tissue samples were subjected to microscopic examinations after hematoxylin and eosin staining. The levels of thiobarbituric acid reactive substances (TBARS), aryllesterase (AES), catalase (CAT), and glutathione S-transferase (GST) enzyme activity were assessed in liver and kidney tissues. The serum levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), blood urea nitrogen (BUN), and creatinine were measured.

Results

A comparison of the groups revealed that the IR group exhibited significantly elevated TBARS (p < 0.0001), AES (p = 0.004), and CAT enzyme activity (p < 0.0001) levels in the liver and kidney compared to groups C and D. Group D-IR demonstrated notably reduced histopathological damage (p < 0.05) and low TBARS (p < 0.0001), AES (p = 0.004), and CAT enzyme activity (p < 0.0001) in the liver and kidney as well as low AST and ALT activity levels (p < 0.0001) in the serum compared to the IR group.

Conclusion

The preemptive administration of dexmedetomidine before pancreatic IR provides significant protection to kidney and liver tissues, as evidenced by the histopathological and biochemical parameters in this study. The findings underscored the potential therapeutic role of dexmedetomidine in mitigating the multiorgan damage associated with pancreatic surgeries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reperfusion InjuryDexmedetomidineKidneyLiverPancreasAnimalsRatsMaleRats, Sprague-Dawley

Stichwörter der Autor:innen

dexmedetomidineischemia-reperfusionkidneyliverpancreas

Substanzen

Dexmedetomidine

Autor:innen und Institutionen

  • Gazi University Faculty of Medicine, Department of General Surgery, Ankara, Turkey.
  • Gazi University Faculty of Medicine Department of Anesthesiology and Reanimation, Ankara, Turkey.
  • Kutahya Health Sciences University Faculty of Medicine, Department of Physiology, Kutahya, Turkey.
  • Kırıkkale University Faculty of Medicine, Department of Histology and Embryology, Kırıkkale, Turkey.
  • Gazi University Faculty of Medicine, Department of Medical Biochemistry, Ankara, Turkey.
  • Gazi University, Life Sciences Application and Research Center, Ankara, Turkey.

ORCID-Profile: Selin Erel, Ayşegül Küçük, Şaban Cem Sezen, Mustafa Arslan

Zitieren

APA

Bostancı, H., Erel, S., Küçük, A., Kip, G., Sezen, Ş. C., Gokgoz, S., Atlı, M., Aktepe, F., Dikmen, K., Arslan, M., & Kavutçu, M. (2024). Dexmedetomidine’s Effects on the Livers and Kidneys of Rats with Pancreatic Ischemia-Reperfusion Injury. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s441773

Vancouver

Bostancı H, Erel S, Küçük A, Kip G, Sezen ŞC, Gokgoz S, et al. Dexmedetomidine’s Effects on the Livers and Kidneys of Rats with Pancreatic Ischemia-Reperfusion Injury. Drug Design, Development and Therapy. 2024. doi:10.2147/dddt.s441773

BibTeX
@article{Bostanc2024,
  author = {Bostancı, Hasan and Erel, Selin and Küçük, Ayşegül and Kip, Gülay and Sezen, Şaban Cem and Gokgoz, Seda and Atlı, Muharrem and Aktepe, Feyza and Dikmen, Kursat and Arslan, Mustafa and Kavutçu, Mustafa},
  title = {Dexmedetomidine’s Effects on the Livers and Kidneys of Rats with Pancreatic Ischemia-Reperfusion Injury},
  journal = {Drug Design, Development and Therapy},
  year = {2024},
  doi = {10.2147/dddt.s441773}
}
Kostenlos starten →